Back
Intra-Cellular Therapies Vs. Philip Morris International Industry Stock Comparison
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
77.09
Seasonality Move:
27.94%
Buy
70
PM
Philip Morris International
Last Price:
131.36
Seasonality Move:
0.72%
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $77.09. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Philip Morris International (PM)
is a Buy
Is Philip Morris International a Buy, Sell or Hold?
- The current Philip Morris International [PM] share price is $131.41. The Score for PM is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- PM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $77.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight selling pressure.
PM Stock Price Chart
What is Philip Morris International's stock price today?
-
The Philip Morris International share price today is $131.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PM is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 58.08 | Buy |
| Chaikin Money Flow: | -3459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.66 - 76.4) | Buy |
| Bollinger Bands (100): | (70.6 - 77.3) | Buy |
PM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 75.48 | Buy |
| Chaikin Money Flow: | 11966320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.32 - 123.16) | Buy |
| Bollinger Bands (100): | (105.09 - 122.71) | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.79 | Buy |
| 20-day SMA: | 74.15 | Buy |
| 50-day SMA: | 74.47 | Buy |
| 200-day SMA: | 71.38 | Buy |
| 8-day EMA: | 75.95 | Buy |
| 20-day EMA: | 74.93 | Buy |
| 50-day EMA: | 74.5 | Buy |
| 200-day EMA: | 70.77 | Buy |
PM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.43 | Buy |
| 20-day SMA: | 120.64 | Buy |
| 50-day SMA: | 121.49 | Buy |
| 200-day SMA: | 103.71 | Buy |
| 8-day EMA: | 122.46 | Buy |
| 20-day EMA: | 121.36 | Buy |
| 50-day EMA: | 119.57 | Buy |
| 200-day EMA: | 108.03 | Buy |
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $1.12 per share.
Philip Morris International Earnings Growth & PM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.66 per share.
Intra-Cellular Therapies Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Philip Morris International Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||